儿科普遍性和焦点性的免疫因素:与抗发作药物的相互作用
1Department of Pediatrics II, Maternity & Child Care Center of Qinhuangdao, No. 452 Hongqi North Road, Haigang District, Qinhuangdao City, Hebei Province, 066000, P. R. China. zhangdongyan2024@163.com.
BMC pediatrics
|March 18, 2025
概括
儿科治疗反应与免疫因素有关. 特定的细胞因子水平和发作特征与儿童抗药物敏感性有显著的相关性.
科学领域:
- 儿科神经学 儿科神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 儿童治疗往往面临着不充分控制发作的挑战.
- 神经炎症和免疫机制越来越多地与病原发生有关.
- 了解免疫和抗发作药物 (ASM) 反应之间的相互作用至关重要.
研究的目的:
- 调查免疫因素在儿科普遍性和焦点性中的作用.
- 探索免疫因素和ASM机制之间的相互作用.
- 确定免疫学因素对儿科治疗结果的影响.
主要方法:
- 一项对136名儿科患者进行的回顾性队列研究.
- 患者被分为ASM敏感 (n=69) 和ASM不敏感 (n=67) 组.
- 评估免疫球蛋白水平,细胞因子 (IL-6,IL-1β,IL-10),发作特征和ASM水平.
主要成果:
- 在ASM敏感和不敏感组之间观察到IL-6,IL-1β和IL-10水平的显著差异.
- 发作频率,抗药性发作和发作严重程度与ASM敏感性有负相关性.
- 无发作期和状态与ASM敏感性正相关.
结论:
- 突出了免疫功能,特征和ASM机制之间的复杂相互作用.
- 强调需要全面了解儿科中药物反应的免疫调节的必要性.
- 表明基于免疫的生物标志物有可能预测ASM反应.
相关概念视频
Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Pharmacokinetics: Drug–Drug Interactions
816
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
816
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
732
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
732
Drug Toxicity: Risk factors
248
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
248
Drug toxicity: Idiosyncratic Reactions
232
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
232
Drug toxicity: Drug–Drug Interaction
437
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
437


